End-of-day quote
Shanghai S.E.
18:00:00 2024-05-21 EDT
|
5-day change
|
1st Jan Change
|
28.12
CNY
|
+1.85%
|
|
+1.41%
|
-39.33%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,197
|
16,638
|
11,641
|
5,468
|
3,317
|
-
|
-
|
Enterprise Value (EV)
1 |
10,197
|
16,638
|
11,641
|
5,468
|
3,317
|
3,317
|
3,317
|
P/E ratio
|
78.7
x
|
115
x
|
87.6
x
|
74.8
x
|
33
x
|
20.1
x
|
20.5
x
|
Yield
|
-
|
-
|
0.14%
|
0.22%
|
0.39%
|
0.59%
|
-
|
Capitalization / Revenue
|
7.37
x
|
7.69
x
|
4.46
x
|
1.97
x
|
1.04
x
|
0.79
x
|
0.89
x
|
EV / Revenue
|
7.37
x
|
7.69
x
|
4.46
x
|
1.97
x
|
1.04
x
|
0.79
x
|
0.89
x
|
EV / EBITDA
|
79.8
x
|
86.4
x
|
62.7
x
|
40.4
x
|
14.1
x
|
10.6
x
|
9.69
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
7.09
x
|
10.6
x
|
4.28
x
|
1.96
x
|
1.16
x
|
1.09
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
106,749
|
106,749
|
117,700
|
117,969
|
117,969
|
-
|
-
|
Reference price
2 |
95.52
|
155.9
|
98.91
|
46.35
|
28.12
|
28.12
|
28.12
|
Announcement Date
|
21-02-25
|
22-02-25
|
23-02-27
|
24-02-25
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,384
|
2,164
|
2,608
|
2,771
|
3,191
|
4,204
|
3,717
|
EBITDA
1 |
127.7
|
192.6
|
185.6
|
135.3
|
236
|
311.7
|
342.5
|
EBIT
1 |
112.6
|
170.7
|
151.7
|
86.36
|
119.1
|
196.5
|
190.1
|
Operating Margin
|
8.13%
|
7.89%
|
5.82%
|
3.12%
|
3.73%
|
4.67%
|
5.11%
|
Earnings before Tax (EBT)
1 |
117.4
|
169.7
|
151.1
|
86.09
|
119
|
196.4
|
189.7
|
Net income
1 |
102.8
|
144
|
124.8
|
72.76
|
100.3
|
224.6
|
161.6
|
Net margin
|
7.42%
|
6.65%
|
4.79%
|
2.63%
|
3.14%
|
5.34%
|
4.35%
|
EPS
2 |
1.214
|
1.350
|
1.129
|
0.6200
|
0.8533
|
1.398
|
1.370
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.1429
|
0.1000
|
0.1100
|
0.1650
|
-
|
Announcement Date
|
21-02-25
|
22-02-25
|
23-02-27
|
24-02-25
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
19.43
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
22-04-27
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
13.8%
|
9.53%
|
6.35%
|
2.64%
|
5.08%
|
6.86%
|
5.31%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
3.8%
|
-
|
2.3%
|
3.8%
|
-
|
Assets
1 |
-
|
-
|
3,282
|
-
|
4,359
|
5,910
|
-
|
Book Value Per Share
2 |
13.50
|
14.80
|
23.10
|
23.70
|
24.30
|
25.90
|
26.40
|
Cash Flow per Share
2 |
-1.290
|
-2.270
|
-1.290
|
-1.060
|
-0.1800
|
0.5600
|
0.2200
|
Capex
1 |
96.5
|
135
|
300
|
463
|
228
|
231
|
194
|
Capex / Sales
|
6.97%
|
6.25%
|
11.49%
|
16.7%
|
7.15%
|
5.5%
|
5.23%
|
Announcement Date
|
21-02-25
|
22-02-25
|
23-02-27
|
24-02-25
|
-
|
-
|
-
|
Last Close Price
28.12
CNY Average target price
36.87
CNY Spread / Average Target +31.10% Consensus |
1st Jan change
|
Capi.
|
---|
| -39.33% | 458M | | +17.82% | 66.74B | | +3.18% | 49.42B | | +20.98% | 42.17B | | +21.48% | 26.37B | | +10.87% | 19.17B | | -1.39% | 16.73B | | +5.83% | 15.99B | | -27.02% | 14.85B | | -12.46% | 14.86B |
Other Specialty Chemicals
|